These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8546473

  • 21. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I, Suzuki M, Tamada T, Nishida M.
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M.
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [Abstract] [Full Text] [Related]

  • 25. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
    Shimoyama T, Shimizu T, Kusano H, Ishikawa H, Miyashita K, Nakazaki T, Yasutake T, Yoshida A, Yoshida K, Ogawa T.
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):125-30. PubMed ID: 8422176
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Tissue concentration of tegafur suppository in patients with head and neck cancer--concentration of 5-FU in cancer tissue].
    Koja S, Itokazu T, Kamiya S, Maeshiro N, Yamauchi M, Esu H, Simoji Y, Kanazawa T, Noda Y.
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):981-5. PubMed ID: 8002637
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
    Schlemmer HP, Becker M, Bachert P, Dietz A, Rudat V, Vanselow B, Wollensack P, Zuna I, Knopp MV, Weidauer H, Wannenmacher M, van Kaick G.
    Cancer Res; 1999 May 15; 59(10):2363-9. PubMed ID: 10344745
    [Abstract] [Full Text] [Related]

  • 30. [Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
    Takeyama M, Honjoh M, Ohnishi N, Ishikawa Y, Sakaguchi H, Hanai J.
    Gan To Kagaku Ryoho; 1993 Oct 15; 20(13):1953-9. PubMed ID: 8215468
    [Abstract] [Full Text] [Related]

  • 31. [A study on UFT concentration in tissues and serum of patients with malignant gynecologic tumors following oral administration].
    Ueda T, Kamiwatari M, Kosya S, Yamamoto S, Shiokawa H, Yamada E, Nagata Y.
    Gan To Kagaku Ryoho; 1987 Jul 15; 14(7):2316-20. PubMed ID: 3111383
    [Abstract] [Full Text] [Related]

  • 32. [UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
    Kato H, Inoue S, Takahashi K, Yamanaka A, Okada Y.
    Gan To Kagaku Ryoho; 1987 Jun 15; 14(6 Pt 1):1866-70. PubMed ID: 3036016
    [Abstract] [Full Text] [Related]

  • 33. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H, Konami T, Konishi T, Pak K, Tomoyoshi T.
    Hinyokika Kiyo; 1986 Oct 15; 32(10):1449-53. PubMed ID: 3105272
    [Abstract] [Full Text] [Related]

  • 34. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH, Pazdur R, Covington W, Brown N, Huo YY, Lassere Y, Kuritani J.
    Clin Cancer Res; 1998 Sep 15; 4(9):2085-8. PubMed ID: 9748123
    [Abstract] [Full Text] [Related]

  • 35. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A, Takagi R, Hoshina H, Ono K, Kaji M, Tsurumaki H, Fukuda J, Nagashima K, Miyaura Y, Hayatsu M, Miyamoto T.
    Gan To Kagaku Ryoho; 2000 Sep 15; 27(10):1527-32. PubMed ID: 11015997
    [Abstract] [Full Text] [Related]

  • 36. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T, Hashimoto I, Sawada Y, Mikami J, Yoshimoto M, Nishidai H, Nakanishi Y, Kashi Y.
    Gan To Kagaku Ryoho; 1984 May 15; 11(5):1037-48. PubMed ID: 6721512
    [Abstract] [Full Text] [Related]

  • 37. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K, Arima S, Yoshimura S, Okamoto T, Yamasaki K, Koto T, Yamasaki S, Kawahara K, Ikuno T.
    Gan To Kagaku Ryoho; 1991 Feb 15; 18(2):215-20. PubMed ID: 1992915
    [Abstract] [Full Text] [Related]

  • 38. [A case of recurrent sigmoid colon cancer successfully treated with 5-FU and UFT].
    Otsuji E, Yamaguchi T, Yamane T, Fujita Y, Takahashi T, Nishioka B.
    Gan To Kagaku Ryoho; 1988 Mar 15; 15(3):523-6. PubMed ID: 3126710
    [Abstract] [Full Text] [Related]

  • 39. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
    Kanimoto Y, Suzuki Y, Miwa Y, Akino H, Isomatu Y, Okada K.
    Hinyokika Kiyo; 1991 Mar 15; 37(3):229-33. PubMed ID: 1648873
    [Abstract] [Full Text] [Related]

  • 40. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M, Ishikawa H, Seki M, Ikeya T, Miyamoto Y, Izuo M, Tozuka S, Usui R, Kaneko H.
    Gan No Rinsho; 1985 Oct 15; 31(13):1697-703. PubMed ID: 3935831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.